CODX

Co-Diagnostics, Inc. Common Stock

1.12

USD

+0.02

+1.82%

Sep 11, 15:55 UTC -4

Closed

Pre-Market

1.13

+0.01

+0.89%

CODX Earnings Reports

Positive Surprise Ratio

CODX beat 17 of 31 last estimates.

55%

Next Report

Date of Next Report

Nov 11, 2026

Estimate for Q3 26 (Revenue/ EPS)

$188.19K

-$2.90

Implied change from Q2 26 (Revenue/ EPS)

+13.37%

+98.63%

Implied change from Q3 25 (Revenue/ EPS)

+29.79%

-39.58%

Co-Diagnostics, Inc. Common Stock earnings per share and revenue

On Aug 13, 2026, CODX reported earnings of -1.46 USD per share (EPS) for Q2 26, beating the estimate of -3.06 USD, resulting in a 52.29% surprise. Revenue reached 166.00 thousand, compared to an expected 169.83 thousand, with a -2.26% difference. The market reacted with a -6.04% price change (close before vs. close after earnings).

Looking ahead to Q3 26, 4 analysts forecast an EPS of -2.90 USD, with revenue projected to reach 188.19 thousand USD, implying an increase of 98.63% EPS, and increase of 13.37% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

MiniMed Group, Inc. Common Stock

Report Date

Sep 01, 2026 For Q1 27

Estimate

$0.09

Actual

$0.00

Surprise

-100.00%

InnovAge Holding Corp. Common Stock

Report Date

Sep 08, 2026 For Q4 26

Estimate

$0.07

Actual

$0.06

Surprise

-19.79%

FAQ

What were Co-Diagnostics, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Co-Diagnostics, Inc. Common Stock reported EPS of -$1.46, beating estimates by 52.29%, and revenue of $166.00K, -2.26% below expectations.

How did the market react to Co-Diagnostics, Inc. Common Stock's Q2 2026 earnings?

The stock price moved down -6.04%, changed from $1.49 before the earnings release to $1.40 the day after.

When is Co-Diagnostics, Inc. Common Stock expected to report next?

The next earning report is scheduled for Nov 11, 2026.

What are the forecasts for Co-Diagnostics, Inc. Common Stock's next earnings report?

Based on 4 analysts, Co-Diagnostics, Inc. Common Stock is expected to report EPS of -$2.90 and revenue of $188.19K for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.